Question explored with the scientific record
Conversation so far
- 1 COVID vaccine experiments on ferrets. Immuniity compromised?
- 2 Did any ferret study test long-term immunity after vaccination?
Answered on this page ↓
Did any ferret study test long-term immunity after vaccination?
The short version: no ferret study in this retrieval tested long-term immunity after COVID-19 vaccination.
None of the retrieved records measured immunity beyond the immediate challenge period. The closest is the Nipah virus pig study, which tracked antibody titers out to 112 days after a single dose [4], but that is a different virus, a different species, and still only antibody levels, not functional long-term protection against reinfection or other pathogens.
The single ferret COVID-19 vaccine study from the previous answer measured viral clearance at 7 and 14 days after challenge [1]. That is short-term efficacy, not long-term immunity. It did not follow the ferrets for months, did not rechallenge them later, and did not test their immune response to unrelated infections.
The broader animal vaccine literature in this retrieval shows the same pattern. The Nipah pig study found that protection waned: significant at 2 and 6 months, not significant at 12 months [3]. The SARS macaque study measured neutralizing antibodies at 9 weeks post-immunization and found them below the detection threshold [2]. Neither is a long-term immunity study.
My call: the evidence does not answer whether COVID-19 vaccination produces durable long-term immunity in ferrets. Confidence: low, because the question was never tested in the studies retrieved.
Sources used 4
-
Routine SARS‐CoV ‐2 vaccination for all children*
The authors argue the benefits of routine SARS-CoV-2 vaccination outweigh the risks for all children and recommend adding it to the routine pediatric vaccine schedule worldwide.
DOI: 10.1111/imr.13108 -
Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
This study evaluates the potential for antibody-dependent enhancement (ADE) of SARS-CoV infection in rhesus macaques immunized with an inactivated SARS-CoV vaccine, finding no evidence of ADE and suggesting the vaccine's safety for clinical trials.
DOI: 10.1007/s12250-018-0009-2 -
Immunological approaches to the control of tuberculosis in wildlife reservoirs
This mini-review surveys immunological approaches to controlling bovine tuberculosis in wildlife reservoirs, focusing on diagnostic tools, vaccine development and delivery strategies, and biological control options for possums, badgers, and African buffalo, with emphasis on immu…
DOI: 10.1016/s0165-2427(00)00163-x -
Nipah virus vaccines evaluated in pigs as a ‘One Health’ approach to protect public health
Three Nipah virus vaccine candidates protected pigs against Nipah virus challenge after prime-boost immunization, but single-dose immunization was not effective at the evaluated time point.
DOI: 10.1038/s41541-025-01212-y